Activity of CDK4/6 inhibitors in translocation renal cell carcinoma

被引：0
|
作者：
Gupta, S. [1 ]
Khanna, P. [1 ]
Saad, E. [1 ]
Saliby, R. [1 ]
Li, J. [1 ]
Li, B. [1 ]
Sadagopan, A. [1 ]
Xu, Q. [1 ]
Bakouny, Z. [1 ]
Lee, G. S. Mary [1 ]
Choueiri, T. K. [1 ]
Viswanathan, S. R. [1 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB043
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [21] Recent Progress in CDK4/6 Inhibitors and PROTACs
    Wang, Hao
    Ba, Jianfei
    Kang, Yue
    Gong, Zeqiao
    Liang, Tingting
    Zhang, Yahong
    Qi, Jianguo
    Wang, Jianhong
    MOLECULES, 2023, 28 (24):
  • [22] Treating cancer with selective CDK4/6 inhibitors
    Ben O'Leary
    Richard S. Finn
    Nicholas C. Turner
    Nature Reviews Clinical Oncology, 2016, 13 : 417 - 430
  • [23] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
  • [24] How selective are clinical CDK4/6 inhibitors?
    Hendrychova, Denisa
    Jorda, Radek
    Krystof, Vladimir
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (03) : 1578 - 1598
  • [25] Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
    Roberts, Patrick J.
    Kumarasamy, Vishnu
    Witkiewicz, Agnieszka K.
    Knudsen, Erik S.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1575 - 1588
  • [26] Developmental therapeutics post CDK4/6 inhibitors
    Yap, Yoon-Sim
    ANNALS OF ONCOLOGY, 2022, 33 : S454 - S454
  • [27] Renoprotective effects of CDK4/6 pathway inhibitors
    Nature Reviews Nephrology, 2015, 11 (6) : 316 - 316
  • [28] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Wu, Xuewei
    Yang, Xiaobao
    Xiong, Yan
    Li, Ruitong
    Ito, Takahiro
    Ahmed, Tamer A.
    Karoulia, Zoi
    Adamopoulos, Christos
    Wang, Hong
    Wang, Li
    Xie, Ling
    Liu, Jing
    Ueberheide, Beatrix
    Aaronson, Stuart A.
    Chen, Xian
    Buchanan, Sean G.
    Sellers, William R.
    Jin, Jian
    Poulikakos, Poulikos I.
    NATURE CANCER, 2021, 2 (04) : 429 - +
  • [29] Inhibitors of CDK4/6 and HIF2a induce immunogenic cell death in merkel cell carcinoma cells
    Lee, J. H.
    Lee, J.
    Pulliam, T.
    Paulson, K.
    Voillet, V.
    Berndt, A.
    Church, C.
    Lachance, K.
    Park, S. Y.
    Cromwell, E.
    Gottardo, R.
    Chapuis, A.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B38 - B38
  • [30] CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
    Garutti, Mattia
    Targato, Giada
    Buriolla, Silvia
    Palmero, Lorenza
    Minisini, Alessandro Marco
    Puglisi, Fabio
    CELLS, 2021, 10 (06)
12345